UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Is 50 mg/day the new standard dose of dasatinib in newly diagnosed patients with chronic myeloid leukemia in chronic phase?

Expert review of hematology, 2024-07, Vol.17 (7), p.275-277

2024

Volltextzugriff (PDF)

The Power of Reordering for Online Minimum Makespan Scheduling

SIAM journal on computing, 2014-01, Vol.43 (3), p.1220-1237

2014

Volltextzugriff (PDF)

Does discontinuing bleomycin due to toxicity increase the risk of lymphoma progression? Real-life data from a homogeneous population of advanced stage Hodgkin lymphoma

Journal of chemotherapy (Florence), 2024-09, Vol.36 (5), p.403-410

2024

Volltextzugriff (PDF)

Ponatinib both as an effective bridge to allogeneic hematopoietic stem cell transplantation and as posttransplant maintenance therapy in a chronic myeloid leukemia patient with myeloid blast crisis

Hematology, Transfusion and Cell Therapy, 2023-04, Vol.45 (2), p.275-277

2023

Volltextzugriff (PDF)

Impact of CALR and JAK2V617F Mutations on Clinical Course and Disease Outcomes in Essential Thrombocythemia: A Multicenter Retrospective Study in Turkish Patients

Turkish journal of haematology, 2024-03, Vol.41 (1), p.26-36

2024

Volltextzugriff (PDF)

Evaluation of contraception methods in chronic myeloid leukemia patients: A Turkish multicenter study

Journal of oncology pharmacy practice, 2024-09, p.10781552241280615

2024

Volltextzugriff (PDF)

Efficacy and Safety of Imatinib Treatment in Elderly Patients With Chronic Myeloid Leukemia: Real-Life Data and a Single-Center Experience

Clinical lymphoma, myeloma and leukemia, 2021-08, Vol.21 (8), p.549-557

2021

Volltextzugriff (PDF)

Evaluation of Hypogammaglobulinemia in Chronic Lymphocytic Leukemia Patients and Its Relation to Poor Prognostic Factors

Haseki tıp bülteni, 2018-09, Vol.56 (3), p.181-186

2018

Volltextzugriff (PDF)

A safety review of tyrosine kinase inhibitors for chronic myeloid leukemia

Expert opinion on drug safety, 2024-04, Vol.23 (4), p.411-423

2024

Volltextzugriff (PDF)

Is There an Immunohistochemical PD-L1 Cut-Off Point That Serves as a Prognostic Indicator for Large B-Cell Lymphomas?

Diagnostics (Basel), 2024-05, Vol.14 (11), p.1167

2024

Volltextzugriff (PDF)

The Incidence of BRAF V600E Mutations and the Impact of Cladribine Treatment on the Incidence of BRAF V600E Mutations and Survival in Hairy Cell Leukemia Patients: A Case-Control Study

Turkiye Klinikleri Journal of Medical Sciences, 2024-03, Vol.44 (2), p.69-75

2024

Volltextzugriff (PDF)

PB2191: A RETROSPECTIVE MULTI‐CENTER STUDY ON DIRECT ORAL ANTICOAGULANT USE IN BCR::ABL1 NEGATIVE MYELOPROLIFERATIVE NEOPLASMS

HemaSphere, 2023-08, Vol.7 (S3), p.e22350da-n/a

2023

Volltextzugriff (PDF)

Impact of CALR and JAK2 V617F Mutations on Clinical Course and Disease Outcomes in Essential Thrombocythemia: A Multicenter Retrospective Study in Turkish Patients

Turkish journal of haematology, 2024-03, Vol.41 (1), p.26

2024

Volltextzugriff (PDF)

Tyrosine kinase inhibitor (TKI) therapy for newly-diagnosed patients with chronic myeloid leukemia: focusing on TKI discontinuation due to adverse events - is better always good?

Expert review of hematology, 2017-07, Vol.10 (7), p.583-586

2017

Volltextzugriff (PDF)

P-193 Impact Of Bone Marrow Fibrosis In Multiple Myeloma At Diagnosis and On DIsease Course

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S149-S149

2024

Volltextzugriff (PDF)

The Real-Life Data on the Outcome of Hepatitis B Infection in Patients with B-Cell Lymphoproliferative Neoplasms Treated with Ibrutinib

Blood, 2019-11, Vol.134 (Supplement_1), p.4316-4316

2019

Volltextzugriff (PDF)

Management of Major Surgical Procedures in Patients with Hemophilia: A Single-Center Experience of 49 Procedures

Blood, 2019-11, Vol.134 (Supplement_1), p.4933-4933

2019

Volltextzugriff (PDF)

Advanced-Stage Hodgkin Lymphoma International Prognostic Index (A-HIPI) in Turkish Patients with Classical Hodgkin Lymphoma: A Single-Center Retrospective Study

European medical journal. Hematology, 2024-07, p.44-46

2024

Volltextzugriff (PDF)

Use of Bendamustine Combined with Rituximab in Chronic Lymphocytic Leukemia Patients: A Single Center Experience

Blood, 2017-12, Vol.130, p.5349-5349

2017

Volltextzugriff (PDF)

Flow Cytometric Analysis of Lymphocyte Subsets of Covid-19 Patients from A Single Centre in Turkey

Acibadem Universitesi Saglik Bilimleri Dergisi, 2023-09, Vol.14 (4)

2023

Volltextzugriff (PDF)

Hepatitis B Virus Seropositivity in Chronic Myeloid Leukemia Patients Receiving Tyrosine Kinase Inhibitors: Preliminary Results of a Single-Center Cross-Sectional Study

Blood, 2017-12, Vol.130, p.2888-2888

2017

Volltextzugriff (PDF)

Progressive Multifocal Leukoencephalopathy in a Patient with Multiple Myeloma

Clinical lymphoma, myeloma and leukemia, 2019-10, Vol.19 (10), p.e241-e241

2019

Volltextzugriff (PDF)

Ponatinib both as an effective bridge to allogeneic hematopoietic stem cell transplantation and as posttransplant maintenance therapy in a chronic myeloid leukemia patient with myeloid blast crisis

Hematology, transfusion and cell therapy, 2023, Vol.45 (2), p.275-277

2023

Volltextzugriff (PDF)

The Power of Reordering for Online Minimum Makespan Scheduling

2008 49th Annual IEEE Symposium on Foundations of Computer Science, 2008, p.603-612

2008

Volltextzugriff (PDF)

The Subject Areas of Post-graduate Theses Completed at Educational Sciences Between 2000-2008

Procedia, social and behavioral sciences, 2012, Vol.46, p.5756-5762

2012

Volltextzugriff (PDF)

1 – 25 von 257

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(218)
Mit Volltextzugriff
(191)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(175)
Life Sciences & Biomedicine
(159)
Humans
(100)
Radiology, Nuclear Medicine & Medical Imaging
(67)
Female
(62)
Male
(57)
Middle Aged
(54)
Adult
(43)
Aged
(38)
Radiology
(31)
Medicine
(29)
Medicine & Public Health
(29)
Magnetic Resonance Imaging
(27)
Imaging
(24)
Patients
(23)
Retrospective Studies
(23)
Medicine, General & Internal
(21)
General & Internal Medicine
(20)
Medical Imaging
(19)
Cardiac & Cardiovascular Systems
(18)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Is 50 mg/day the new standard dose of dasatinib in newly diagnosed patients with chronic myeloid leukemia in chronic phase?

The Power of Reordering for Online Minimum Makespan Scheduling

Does discontinuing bleomycin due to toxicity increase the risk of lymphoma progression? Real-life data from a homogeneous population of advanced stage Hodgkin lymphoma

Ponatinib both as an effective bridge to allogeneic hematopoietic stem cell transplantation and as posttransplant maintenance therapy in a chronic myeloid leukemia patient with myeloid blast crisis

Impact of CALR and JAK2V617F Mutations on Clinical Course and Disease Outcomes in Essential Thrombocythemia: A Multicenter Retrospective Study in Turkish Patients

Evaluation of contraception methods in chronic myeloid leukemia patients: A Turkish multicenter study

Efficacy and Safety of Imatinib Treatment in Elderly Patients With Chronic Myeloid Leukemia: Real-Life Data and a Single-Center Experience

Evaluation of Hypogammaglobulinemia in Chronic Lymphocytic Leukemia Patients and Its Relation to Poor Prognostic Factors

A safety review of tyrosine kinase inhibitors for chronic myeloid leukemia

Is There an Immunohistochemical PD-L1 Cut-Off Point That Serves as a Prognostic Indicator for Large B-Cell Lymphomas?

The Incidence of BRAF V600E Mutations and the Impact of Cladribine Treatment on the Incidence of BRAF V600E Mutations and Survival in Hairy Cell Leukemia Patients: A Case-Control Study

PB2191: A RETROSPECTIVE MULTI‐CENTER STUDY ON DIRECT ORAL ANTICOAGULANT USE IN BCR::ABL1 NEGATIVE MYELOPROLIFERATIVE NEOPLASMS

Impact of CALR and JAK2 V617F Mutations on Clinical Course and Disease Outcomes in Essential Thrombocythemia: A Multicenter Retrospective Study in Turkish Patients

Tyrosine kinase inhibitor (TKI) therapy for newly-diagnosed patients with chronic myeloid leukemia: focusing on TKI discontinuation due to adverse events - is better always good?

P-193 Impact Of Bone Marrow Fibrosis In Multiple Myeloma At Diagnosis and On DIsease Course

The Real-Life Data on the Outcome of Hepatitis B Infection in Patients with B-Cell Lymphoproliferative Neoplasms Treated with Ibrutinib

Management of Major Surgical Procedures in Patients with Hemophilia: A Single-Center Experience of 49 Procedures

Advanced-Stage Hodgkin Lymphoma International Prognostic Index (A-HIPI) in Turkish Patients with Classical Hodgkin Lymphoma: A Single-Center Retrospective Study

Use of Bendamustine Combined with Rituximab in Chronic Lymphocytic Leukemia Patients: A Single Center Experience

Flow Cytometric Analysis of Lymphocyte Subsets of Covid-19 Patients from A Single Centre in Turkey

Hepatitis B Virus Seropositivity in Chronic Myeloid Leukemia Patients Receiving Tyrosine Kinase Inhibitors: Preliminary Results of a Single-Center Cross-Sectional Study

Progressive Multifocal Leukoencephalopathy in a Patient with Multiple Myeloma

Ponatinib both as an effective bridge to allogeneic hematopoietic stem cell transplantation and as posttransplant maintenance therapy in a chronic myeloid leukemia patient with myeloid blast crisis

The Power of Reordering for Online Minimum Makespan Scheduling

The Subject Areas of Post-graduate Theses Completed at Educational Sciences Between 2000-2008

Suchergebnisse filtern